David Weinstein MD PhD
As we continue to await a meaningful treatment becoming available and/or progressing in the clinical trial setting, I have more photo results from RiverTown Therapeutics Inc. to share. This result is a continuation of a previous before and after of a 60 yr old male that has been shared on Follicle Thought from RiverTown. This…
Read MoreA lot has changed in the hair growth industry since I began Follicle Thought three years ago. Many new names and glimmers of hope have shown up in the industry. Even celebrity hair restoration has become more widespread and talked about. These are all positive developments which support the ultimate goal we are heading towards.…
Read MoreI’ve had many readers inquire lately about the current progress of RiverTown Therapeutics Inc.’s RT1640. RTI’s therapy for hair regeneration, RT1640, is a topical medication composed of minoxidil, cyclosporine A, and a novel molecule called RT175. The company debuted some impressive hair growth photos on this site last year. The question that’s been on a…
Read MoreHello everyone, and welcome to another edition of Weekly Thoughts. Things have been really busy in the hair world as of late, new companies are popping up all the time and companies that we have known about are finally making the announcements we want to hear. Lo and behold it’s almost been two months since…
Read MoreI’m very happy to be bringing you all an incredible exclusive on Follicle Thought. This week, David Weinstein, MD, PhD of RiverTown Therapeutics Inc. reached out to me to share some amazing photo results of his new compound RT1640. Below you will find photographs of a 60+ year old woman and a 42 year old…
Read MoreHello Everyone, Welcome to another edition of Weekly Thoughts. This edition features a presentation update on the JAK inhibitor therapies for hair growth and the announcement of a new startup/treatment for hair growth that is also claimed to restore hair pigment. Wowzas. Let’s take a look. Aclaris Therapeutics Jeffries Presentation Acalaris Therapeutics CEO Dr. Neal…
Read More